3rtp
From Proteopedia
| Line 1: | Line 1: | ||
| - | + | {{STRUCTURE_3rtp| PDB=3rtp | SCENE= }} | |
| + | ===Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration=== | ||
| + | {{ABSTRACT_PUBMED_21813278}} | ||
| - | + | ==Disease== | |
| + | [[http://www.uniprot.org/uniprot/MK10_HUMAN MK10_HUMAN]] Defects in MAPK10 are a cause of epileptic encephalopathy Lennox-Gastaut type (EELG) [MIM:[http://omim.org/entry/606369 606369]]. Epileptic encephalopathies of the Lennox-Gastaut group are childhood epileptic disorders characterized by severe psychomotor delay and seizures. Note=A chromosomal aberration involving MAPK10 has been found in a single patient. Translocation t(Y;4)(q11.2;q21) which causes MAPK10 truncation. | ||
| - | + | ==Function== | |
| + | [[http://www.uniprot.org/uniprot/MK10_HUMAN MK10_HUMAN]] Serine/threonine-protein kinase involved in various processes such as neuronal proliferation, differentiation, migration and programmed cell death. Extracellular stimuli such as proinflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK10/JNK3. In turn, MAPK10/JNK3 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN and ATF2 and thus regulates AP-1 transcriptional activity. Plays regulatory roles in the signaling pathways during neuronal apoptosis. Phosphorylates the neuronal microtubule regulator STMN2. Acts in the regulation of the beta-amyloid precursor protein/APP signaling during neuronal differentiation by phosphorylating APP. Participates also in neurite growth in spiral ganglion neurons.<ref>PMID:11718727</ref> | ||
| - | + | ==About this Structure== | |
| + | [[3rtp]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3RTP OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <references group="xtra"/><references/> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Mitogen-activated protein kinase]] | ||
| + | [[Category: Artis, D R.]] | ||
| + | [[Category: Bard, F.]] | ||
| + | [[Category: Bowers, S.]] | ||
| + | [[Category: Chan, W.]] | ||
| + | [[Category: Chen, L.]] | ||
| + | [[Category: Dryer, M.]] | ||
| + | [[Category: Galemmo, R A.]] | ||
| + | [[Category: Goldbach, E.]] | ||
| + | [[Category: Griswold-Prenne, I.]] | ||
| + | [[Category: Hom, R K.]] | ||
| + | [[Category: Konradi, A W.]] | ||
| + | [[Category: Lin, M.]] | ||
| + | [[Category: Lorentzen, C.]] | ||
| + | [[Category: Neitz, R J.]] | ||
| + | [[Category: Pan, H.]] | ||
| + | [[Category: Peterson, B.]] | ||
| + | [[Category: Powell, K.]] | ||
| + | [[Category: Probst, G D.]] | ||
| + | [[Category: Quincy, Q.]] | ||
| + | [[Category: Quinn, K P.]] | ||
| + | [[Category: Ren, Z.]] | ||
| + | [[Category: Ruslim, L.]] | ||
| + | [[Category: Samant, B.]] | ||
| + | [[Category: Sauer, J.]] | ||
| + | [[Category: Sealy, J M.]] | ||
| + | [[Category: Sham, H L.]] | ||
| + | [[Category: Tonn, G.]] | ||
| + | [[Category: Truong, A P.]] | ||
| + | [[Category: Wong, K.]] | ||
| + | [[Category: Wright, S.]] | ||
| + | [[Category: Yao, N.]] | ||
| + | [[Category: Yednock, T A.]] | ||
| + | [[Category: Zhang, H.]] | ||
| + | [[Category: Zmolek, W.]] | ||
| + | [[Category: Jnk inhibitor]] | ||
| + | [[Category: Neurodegeneration]] | ||
| + | [[Category: Pharmacokinetic property]] | ||
| + | [[Category: Transferase-transferase inhibitor complex]] | ||
Revision as of 07:40, 8 May 2013
Contents |
Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration
Template:ABSTRACT PUBMED 21813278
Disease
[MK10_HUMAN] Defects in MAPK10 are a cause of epileptic encephalopathy Lennox-Gastaut type (EELG) [MIM:606369]. Epileptic encephalopathies of the Lennox-Gastaut group are childhood epileptic disorders characterized by severe psychomotor delay and seizures. Note=A chromosomal aberration involving MAPK10 has been found in a single patient. Translocation t(Y;4)(q11.2;q21) which causes MAPK10 truncation.
Function
[MK10_HUMAN] Serine/threonine-protein kinase involved in various processes such as neuronal proliferation, differentiation, migration and programmed cell death. Extracellular stimuli such as proinflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK10/JNK3. In turn, MAPK10/JNK3 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN and ATF2 and thus regulates AP-1 transcriptional activity. Plays regulatory roles in the signaling pathways during neuronal apoptosis. Phosphorylates the neuronal microtubule regulator STMN2. Acts in the regulation of the beta-amyloid precursor protein/APP signaling during neuronal differentiation by phosphorylating APP. Participates also in neurite growth in spiral ganglion neurons.[1]
About this Structure
3rtp is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- ↑ Neidhart S, Antonsson B, Gillieron C, Vilbois F, Grenningloh G, Arkinstall S. c-Jun N-terminal kinase-3 (JNK3)/stress-activated protein kinase-beta (SAPKbeta) binds and phosphorylates the neuronal microtubule regulator SCG10. FEBS Lett. 2001 Nov 16;508(2):259-64. PMID:11718727
Categories: Homo sapiens | Mitogen-activated protein kinase | Artis, D R. | Bard, F. | Bowers, S. | Chan, W. | Chen, L. | Dryer, M. | Galemmo, R A. | Goldbach, E. | Griswold-Prenne, I. | Hom, R K. | Konradi, A W. | Lin, M. | Lorentzen, C. | Neitz, R J. | Pan, H. | Peterson, B. | Powell, K. | Probst, G D. | Quincy, Q. | Quinn, K P. | Ren, Z. | Ruslim, L. | Samant, B. | Sauer, J. | Sealy, J M. | Sham, H L. | Tonn, G. | Truong, A P. | Wong, K. | Wright, S. | Yao, N. | Yednock, T A. | Zhang, H. | Zmolek, W. | Jnk inhibitor | Neurodegeneration | Pharmacokinetic property | Transferase-transferase inhibitor complex
